Three patients, self-reported
A case series described three patients with nerve pain who used very low amounts of psilocybin and reported relief.
Worth knowing
There was no control group and the reports came from the patients themselves. Reviews rate the evidence as low or very low certainty.
Lyes et al., Pain, 2022
Microdosing psilocybin for chronic pain: a case series →